Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Project aims to increase understanding, reduce stigma, and improve the quality of life of people living with sickle cell disease.

A yellow background with decorative images. In the top left hand corner is the logo for the Oxford Blood Group. In the top right hand corner is the logo for the University of Oxford. In the centre is written 'Racism and Sickle Cell Disorder: How race and racism impact quality of care for people in the SCD community and how we can change things for the better.'

Sickle Cell Disorder (SCD) is a genetically inherited condition affecting almost exclusively people of Black African and Afro-Caribbean origin.

In the light of the international Black Lives Matter movement, Drs Noémi Roy and Catriona Gilmour Hamilton hosted a series of workshops at Oxford University Hospitals NHS Foundation Trust to explore and address overt or unconscious racism towards sickle cell patients.

Critical to the success of the workshops was bringing together a core group to steer the process. This group included two patients, two doctors, two facilitators and two patient experience experts. They met several times to think through sensitive issues ahead of time, and to debrief after each event. Additionally, the workshop moderators met each participant 1:1 on Zoom before the group meetings, in order to build rapport and enable each participant to feel comfortable sharing their experiences during the workshops.

25 participants attended the workshops, representing SCD patients, community leaders, health professionals as well as medical students. 60-70% of the group identified as Black or ethnic minority. Over the three workshops, there were guided discussions which included sharing experiences and stories, highlighting challenging areas, identifying the most important challenges, and working on actions to follow up the discussions. Three distinct areas emerged for further activity, one relating to training of medical students about SCD and racism issues, a second to disseminate the findings of the workshops, for example at the UK Forum for Haemoglobinopathy Disorders in November, and third to continue to provide opportunities for individuals to share their stories through an ongoing podcast listening project.

Many of the participants reported that taking part in the workshops had been a positive experience for them. Several mentioned that they had found confidence to challenge behaviours and to advocate for better care for SCD patients.

“As a result of the workshops, I will be bold, be confident, be courageous – have the difficult conversations and tell my story as someone living with sickle cell and working in healthcare. Dream big!” said one participant.

Another participant reflected “I now have greater awareness of racism and the experiences of people of colour in the health service. I am maintaining my commitment to the power of stories”.

The group plans to meet in six months’ time to see what progress has been made. This project was supported by the University of Oxford’s PER Seed Fund supported by the ISSF.

To see the original announcement of this funding award, visit: https://www.imm.ox.ac.uk/news/msd-projects-awarded-public-engagement-seed-funding-2020-21

Similar stories

Study of T-cell receptor activation leads to surprising discovery

A study from Davis Group is the first to describe the structure of the T-cell receptor when bound to an activating ligand. The findings shed light on an important trigger in the immune system, and suggest a completely new process by which cell receptors can be activated.

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Prof. Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Seven research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’

Playful science at Wheatley and Holton Play and Activity Day 2022

On Saturday 16th July, volunteers from the MRC WIMM talked the science of blood, lab techniques and coding at the Play and Activity Day organised by the Oxfordshire Play Association.

Sun shines for MRC MHU Summer Party

A new event for this year, the day saw people from across the Unit facilities and admin teams gather for an afternoon of ice-cream, games and food.